San Diego, November 2023 – La Vita Compounding Pharmacy, a trusted 503A compounding pharmacy, is proud to announce its acquisition by a strategic buyer. The acquisition comes as part of the buyer’s strategic vision to build a national platform in the compounding pharmacy industry, leveraging the expertise and reputation of La Vita as they expand their reach to serve patients across the United States for anti-aging, behavioral health and integrative therapies.
Deb Hubers, co-founder of La Vita Compounding Pharmacy, expressed her enthusiasm about this development: “We are thrilled to have found a partner who shares our commitment to quality and patient care. This partnership will undoubtedly provide new opportunities for our staff and further benefit the patients we serve. We believe our legacy of exceptional compounding services will continue to thrive under the new ownership.”
The buyer, equally excited about this acquisition, stated: “We are impressed with La Vita’s strong reputation and commitment to quality compounding services. This acquisition aligns with our strategic plan to create a leading national compounding pharmacy platform, and we are eager to work alongside the talented La Vita team.”
Harbor Healthcare Consultants served as the exclusive sell-side advisor to La Vita Compounding Pharmacy throughout the acquisition process. Mark Alford, Managing Director, commented, “This transaction represents a successful partnership between La Vita and the strategic buyer, and I am proud to have played a role in bringing these two parties together. It’s a testament to La Vita’s strong position in the market and their commitment to providing exceptional patient care.”
About La Vita Compounding Pharmacy
La Vita Compounding Pharmacy is a leading 503A compounding pharmacy located in San Diego, California. For over a decade, La Vita has been dedicated to providing high-quality compounded medications tailored to meet the unique needs of patients and healthcare providers. Their commitment to excellence and patient care has made them a trusted source for compounding services throughout California.
About the Acquiring Pharmacy
The acquirer is a 503A compounding pharmacy specializing in a variety of compounded dosage forms in sterile and non-sterile environments. By providing better patient outcomes through quality compounding, they remain at the nationwide forefront of the compounding pharmacy segment. The pharmacy is licensed in nearly all 50 states and provides medication for anti-aging and integrative therapies.
About the Harbor Healthcare
Harbor Healthcare is a boutique M&A advisory firm founded in 1995 by its President and pharmacist, Ira Cammeyer, who is actively involved in guiding strategic initiatives at the company. Harbor offers a variety of M&A advisory services to middle market healthcare and pharmacy businesses. The company provides perceptive strategic solutions to independent owners and investors of long-term care, specialty, home infusion, compounding and 340B pharmacies. Harbor offers regulatory and advisory expertise while maintaining business relationships with strategic, private equity and independent acquirers. For more information, please contact Mark Alford, Managing Director at Harbor Healthcare (619) 535-9005 or visit https://www.harborhealthcare.com.
Click Here for a Sample of Our M&A Transactions
Select Transactions